This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Steroid-eluting Spongostan improves endoscopic DCR success

Steroid-eluting Spongostan improves endoscopic DCR success
Reviewed by James Hsuan

3 February 2023 | James Hsuan | EYE - Oculoplastic, EYE - Orbit
Share This

This is a retrospective analysis of a change in technique for endoscopic dacryocystorhinostomy (endo-DCR) surgery. The authors compared the outcomes of 55 patients between 2011 and 2013 with 187 from 2013 to 2020 who all underwent endo-DCR. In 2013 the authors changed their technique and instead of placing a saline-soaked Spongostan on the lateral wall of the nose over the rhinostomy site, they used one soaked in Depo-Medrol (methylprednisolone acetate). All patients were given steroid and antibiotic eyedrops and steroid nasal spray postoperatively. Anatomical success was defined as an open ostium and free passage of fluid into the nose on syringing. Functional success was defined as an absence of epiphora as reported by the patient. In the saline group, the anatomical and functional success rates were 90.9% and 83.6% respectively, compared with 94.6% and 93.4% in the steroid group. The difference was statistically significant (p<0.05) in functional success, but not anatomical success. There were no additional complications attributable to the steroid. The main drawback of the study is its retrospective nature and the inability to account for increased surgical experience biasing the results from a learning curve effect, as all operations were carried out jointly by the same two surgeons (otolaryngologist and oculoplastic surgeon) over the 10 year period. The authors do consider this and suggest that as the failure rate did not vary year by year, this is not a major factor. Although the beneficial nature of the steroid-eluting Spongostan cannot be proven without a masked randomised controlled trial, the study does provide good evidence of its effectiveness.

Introduction of steroid absorbed Spongostan in endoscopic dacryocystorhinostomy improves success rates.
Chen I, Ayalon H, Drabkin E, et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
2022;38(5):444-7
Share This
James Hsuan
CONTRIBUTOR
James Hsuan

Aintree University Hospital, Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency